The U.S. Deep Learning Market is Projected to Grow from $37.14 Billion in 2025 to $596.02 Billion by 2035, While Europe is Expected to Expand from $31.98 Billion to $451.64 Billion, Fueled by Rapid ...

Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on ...

Deep learning variant calling has transformed genomic accuracy. Discover how DeepVariant works, outperforms classical tools, ...

Improve model performance and training stability using multilayer perceptrons (MLPs) and applying normalization techniques. Implement autoencoders for unsupervised feature learning and design ...

The latest ambition of artificial intelligence research — particularly within the labs seeking “artificial general intelligence,” or AGI — is something called a world model: a representation of the ...

Deep learning is a branch of machine learning based on algorithms that try to model high-level abstract representations of data by using multiple processing layers with complex structures. One of the ...

Key market opportunities in generative AI for drug discovery include the integration of AI in drug pipelines, demand for accelerated drug discovery, and biologics optimization. Rising clinical trials ...

Now in its ninth year, AI Breakthrough recognizes Roadzen alongside Qualcomm, AMD, Dell Technologies, Snowflake, Intuit, SoundHound, Superhuman among this year's leading AI innovators ...

The programme aims to equip professionals build production-grade AI capabilities across machine learning, deep learning, MLOps, cybersecurity, Generative AI, LLMs and agentic AI systems.

Artificial intelligence (AI) in research histopathology is turning whole-slide images of preclinical tissue into structured, quantitative data rather than a pathologist's subjective impression alone.